o Kopilk spots: Generally not seen in clinic because they disappear 2 days prior to rash Located in buccal mucosa opposite lower second molar as a bluish spot M/Ccomplication: Serous otitis media Rare complication: SSPE (subacute sclerosing IP:2-3 weeks panencephalitis) Source: Cases o Generally seen after 7-10 y of measles infection Mode of transmission: Resp. (air droplets) o Ata rate of 7/million Period of communicability: 4-6 days prior to symptoms to7 days later Vaccine 00:10:53 SAR:>86% Active immunity Type: Live attenuated c M/Ccomplication: Aseptic meningitis Strain: Edmonston Zagreb strain c Children: Aseptic meningitis Adolescents males: Orchitis Route: subcutaneous Adolescents Females: Oophoritis Schedule 2 doses Adult: Meningoencephalitis ’9 months M/Cage group: 5-9 years ’ 16-24 months Vaccine component: MMR Diluent: Distilled water or sterile water o Type: live attenuated Site: Right arm, subcutaneous route o Strain: Jerylllynn strain Immunoglobulin: Passive immunity GERMAN MEASLES (RUBELLA) O 00:16:41 o 0.25m/Kg BW Cause: RNA Togavirus " IP: 14-21 days Source: cases, no carriers, no iceberg phenomena e Important Information Mode of transmission: 3 Resp (air droplets) o Transmit vertically (mother to child) " Twodoses of vaccine is known as AMMRS (Accelerated Period of communicability:1 week prior to measles mortalityreduction strategy) 1 week later symptoms to Vaccinetype o MMR, MR(component) ? Previous Year's Questions o Live attenuated Given subcutaneously in right arm c Lyophilsed (Reconstitute with diluent distilled water Q. Subacute Sclerosing Panencephalitis (SSPE) is orsterile water) complication of? (FMGE Dec 2019) Strain: RA 27/3 A. Measles Pregnancy: C/ B. Mumps First priority group: Non pregnant, non-lactating 15-49 y C. Rubella females D. Varicella Can be transmitted from infected mother to unborn or new born child known as CRS (Congenital Rubella
